Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93]

Affiliations

• ¹ Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China.
• ² Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, China.
• ³ Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China. Electronic address: [email protected].